COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now
COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now
复制标题
DOI：
10.1377/hlthaff.2020.01523
复制
发表时间：
2021-01-01
期刊：
影响因子：
9.7
通讯作者：
Rosenberg, Julie
中科院分区：
文献类型：
--
作者：
Weintraub, Rebecca L.;Subramanian, Laura;Rosenberg, Julie
在世界范围内，各国领导人正在实施非药物干预措施，以减缓新型冠状病毒的传播，同时寻求疫苗，赋予免疫力的严重急性呼吸道综合征冠状病毒-2（SARS-CoV-2）感染。在这篇文章中，我们描述了从过去的流行病和疫苗运动中获得的关于成功接种疫苗的经验教训。历史记录表明，要使人口得到广泛免疫，领导人必须投资于循证疫苗提供战略，以产生需求，分配和分发疫苗，并核实覆盖率。为了产生需求，必须了解疫苗犹豫的根源，让可信的权威人士参与疫苗接种的宣传，并承诺与社区进行纵向接触。为了分配疫苗，必须允许合格的组织和专家联盟确定基于证据的疫苗接种方法，并产生确保地方和国家政府合作的政治意愿。为了分发疫苗，必须让在制造、供应链和最后一英里分发方面具有专业知识的人员和组织来指导工作。为了验证疫苗覆盖率，必须确定便携式、可互操作和安全的疫苗接种跟踪系统。过去大流行的教训表明，各国应投资于循证战略，以确保2019冠状病毒病（COVID-19）疫苗保护个人，抑制传播，并最大限度地减少对卫生服务和生计的干扰。
Worldwide, leaders are implementing nonpharmaceutical interventions to slow transmission of the novel coronavirus while pursuing vaccines that confer immunity to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. In this article we describe lessons learned from past pandemics and vaccine campaigns about the path to successful vaccine delivery. The historical record suggests that to have a widely immunized population, leaders must invest in evidence-based vaccine delivery strategies that generate demand, allocate and distribute vaccines, and verify coverage. To generate demand, there must be an understanding of the roots of vaccine hesitancy, involvement of trusted sources of authority in advocacy for vaccination, and commitment to longitudinal engagement with communities. To allocate vaccines, qualified organizations and expert coalitions must be allowed to determine evidence-based vaccination approaches and generate the political will to ensure the cooperation of local and national governments. To distribute vaccines, the people and organizations with expertise in manufacturing, supply chains, and last-mile distribution must be positioned to direct efforts. To verify vaccine coverage, vaccination tracking systems that are portable, interoperable, and secure must be identified. Lessons of past pandemics suggest that nations should invest in evidence-informed strategies to ensure that coronavirus disease 2019 (COVID-19) vaccines protect individuals, suppress transmission, and minimize disruption to health services and livelihoods.